FDA
approval
· 2024-05-24
FDA Approved: CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION — Supplemental Application (Bajaj Medical, LLC)
Summary
FDA approved a supplemental application for Bajaj Medical, LLC to market chlorhexidine gluconate 0.12% oral rinse solution under an approved ANDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION (CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION)